Xie Yibo, Bourgeois Daniel, Guo Beibei, Zhang Rui
Department of Physics and Astronomy, Louisiana State University, Baton Rouge, LA, USA.
Department of Radiation Oncology, Mary Bird Perkins Cancer Center, Baton Rouge, LA, USA.
Med Dosim. 2020;45(1):34-40. doi: 10.1016/j.meddos.2019.04.005. Epub 2019 May 23.
Postmastectomy radiotherapy (PMRT) has been shown to improve the overall survival for invasive breast cancer patients, and many advanced radiotherapy technologies were adopted for PMRT. The purpose of our study is to compare various advanced PMRT techniques including fixed-beam intensity-modulated radiotherapy (IMRT), non-coplanar volumetric modulated arc therapy (NC-VMAT), multiple arc VMAT (MA-VMAT), and tomotherapy (TOMO). Results of standard VMAT and mixed beam therapy that were published by our group previously were also included in the plan comparisons. Treatment plans were produced for nine PMRT patients previously treated in our clinic. The plans were evaluated based on planning target volume (PTV) coverage, dose homogeneity index (DHI), conformity index (CI), dose to organs at risk (OARs), normal tissue complication probability (NTCP) of pneumonitis, lifetime attributable risk (LAR) of second cancers, and risk of coronary events (RCE). All techniques produced clinically acceptable PMRT plans. Overall, fixed-beam IMRT delivered the lowest mean dose to contralateral breast (1.56 ± 0.4 Gy) and exhibited lowest LAR (0.6 ± 0.2%) of secondary contralateral breast cancer; NC-VMAT delivered the lowest mean dose to lungs (7.5 ± 0.8 Gy), exhibited lowest LAR (5.4 ± 2.8%) of secondary lung cancer and lowest NTCP (2.1 ± 0.4%) of pneumonitis; mixed beam therapy delivered the lowest mean dose to heart (7.1 ± 1.3 Gy) and exhibited lowest RCE (8.6 ± 7.1%); TOMO plans provided the most optimal target coverage while delivering higher dose to OARs than other techniques. Both NC-VMAT and MA-VMAT exhibited lower values of all OARs evaluation metrics compare to standard VMAT. Fixed-beam IMRT, NC-VMAT, and mixed beam therapy could be the optimal radiation technique for certain breast cancer patients after mastectomy.
乳房切除术后放疗(PMRT)已被证明可提高浸润性乳腺癌患者的总生存率,并且许多先进的放疗技术已被应用于PMRT。我们研究的目的是比较各种先进的PMRT技术,包括固定束强度调制放疗(IMRT)、非共面容积调强弧形放疗(NC-VMAT)、多弧VMAT(MA-VMAT)和断层放疗(TOMO)。我们团队之前发表的标准VMAT和混合束治疗的结果也纳入了计划比较。为我们诊所之前治疗的9例PMRT患者制定了治疗计划。根据计划靶区(PTV)覆盖情况、剂量均匀性指数(DHI)、适形指数(CI)、危及器官(OARs)的剂量、肺炎的正常组织并发症概率(NTCP)、二次癌症的终身归因风险(LAR)和冠状动脉事件风险(RCE)对计划进行评估。所有技术均产生了临床可接受的PMRT计划。总体而言,固定束IMRT对侧乳房的平均剂量最低(1.56±0.4 Gy),对侧乳房继发癌的LAR最低(0.6±0.2%);NC-VMAT对肺的平均剂量最低(7.5±0.8 Gy),继发肺癌的LAR最低(5.4±2.8%),肺炎的NTCP最低(2.1±0.4%);混合束治疗对心脏的平均剂量最低(7.1±1.3 Gy),RCE最低(8.6±7.1%);TOMO计划提供了最优化的靶区覆盖,同时对OARs的剂量高于其他技术。与标准VMAT相比,NC-VMAT和MA-VMAT的所有OARs评估指标值均较低。固定束IMRT、NC-VMAT和混合束治疗可能是某些乳房切除术后乳腺癌患者的最佳放疗技术。